Boiron websites place tools, info in mom’s hands
Boiron this past fall administered an online makeover across its Oscillo.com site and introduced three additional Internet destinations: ChildrensOscillo.com, Chestal.com and ChildrensChestal.com. The new websites all feature helpful tips for staying healthy and offer Web visitors money-saving coupons.
According to Boiron’s independent research, lack of knowledge regarding homeopathic medicine is the key barrier to usage. After shoppers were given a minimal definition of homeopathic medicines highlighting the benefits, 29% of the category users said they were then interested in trying a homeopathic cough medicine for their children. And because more moms are researching children’s remedies online, establishing resource-rich destination centers seems the smart move.
In addition to creating an interactive online go-to for cough-and-cold information, the homeopathic manufacturer also recently partnered with SDI Health (soon to be part of the IMS Health family) on a cold-and-flu illness tracker. That site, Oscillo.com/flu-tracker, helped tabulate the growing incidence of cold and flu in the middle of last month, even tracking reported symptoms. As of Feb. 18, some of the most prevalent indications were fever (10.8%) and influenza-like symptoms, such as chills, body aches and headache (22.2%).
PPIs time out to Tums
NEW YORK — Sure, the plethora of proton-pump inhibitors dotting digestive aisles these days have generated plenty of buzz among antacids, but what do heartburn sufferers do while they wait for the PPI to begin working? They turn to an immediate relief option like the Tums and Tums Ultra brands, which together generated growth of 96.3% to $24.9 million for the 12 weeks ended Jan. 23 across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.
According to GlaxoSmithKline, immediate relief holds a 63% share of stomach with almost four times more buyers than PPIs and H2 blockers.
Q&A: Rundown on cancer — Andrew Spiegel, CCA
March is National Colorectal Cancer Awareness Month. In support of that, Boehringer Ingelheim’s Dulcolax brand this year has partnered with the Colon Cancer Alliance. Following is CCA’s CEO Andrew Spiegel on that partnership:
DSN: How has Dulcolax partnered with CCA?
Andrew Spiegel: For 2011, Dulcolax is the title sponsor of the Colon Cancer Alliance’s Undy 5000 5K walk/runs [where] participants are given a pair of boxer-style shorts. … Dulcolax has also included the CCA as a donor for each box of Dulcolax sold during this campaign.
DSN: With the 14 Undy 5000s scheduled for this year, how many walkers and runners are expected to participate?
Spiegel: We expect well over 10,000 walkers to attend these popular walks and tens of thousands more supporting those walkers. Over $1 million will be raised.
DSN: What is the link between a laxative product and colon cancer?
Spiegel: One of the frequent symptoms CRC patients report is a change in the bowel habits. … But it is important to discuss any changes in bowel habits, including changes that might require use of a laxative, with your physician, and discuss whether screening for colorectal cancer makes sense.